Drug Shortage Report for TADALAFIL
Report ID | 133791 |
Drug Identification Number | 02455374 |
Brand name | TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4 |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2021-02-11 |
Estimated end date | 2021-03-16 |
Actual end date | 2021-03-18 |
Shortage status | Resolved |
Updated date | 2021-03-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-03-19 | English | Compare |
v5 | 2021-03-18 | French | Compare |
v4 | 2021-03-18 | English | Compare |
v3 | 2021-02-12 | English | Compare |
v2 | 2021-02-11 | French | Compare |
v1 | 2021-02-11 | English | Compare |
Showing 1 to 6 of 6